5 more states sue Purdue Pharma over alleged role in opioid crisis

इंडिया समाचार समाचार

5 more states sue Purdue Pharma over alleged role in opioid crisis
इंडिया ताज़ा खबर,इंडिया मुख्य बातें
  • 📰 ABC
  • ⏱ Reading Time:
  • 27 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 51%

Five more states are suing OxyContin maker Purdue Pharma for its alleged role in the U.S. opioid crisis, the states' attorneys general announce.

Five more states are suing OxyContin maker Purdue Pharma for its alleged role in the U.S. opioid crisis, the states' attorneys general announced on Thursday.

Wisconsin is also suing Richard Sackler, the former president of the company, in addition to the company that his family controls. The news comes one day after New York's Metropolitan Museum of Art announced it was following other cultural institutions in severing ties with the Sackler family, who have been prolific donors to the museum.In a statement, Purdue said it"vigorously denies the allegations in the lawsuits filed today and will continue to defend itself against these misleading attacks."

हमने इस समाचार को संक्षेप में प्रस्तुत किया है ताकि आप इसे तुरंत पढ़ सकें। यदि आप समाचार में रुचि रखते हैं, तो आप पूरा पाठ यहां पढ़ सकते हैं। और पढो:

ABC /  🏆 471. in US

इंडिया ताज़ा खबर, इंडिया मुख्य बातें

Similar News:आप इससे मिलती-जुलती खबरें भी पढ़ सकते हैं जिन्हें हमने अन्य समाचार स्रोतों से एकत्र किया है।

Five more states sue Purdue Pharma for opioid crisisFive more states sue Purdue Pharma for opioid crisisWest Virginia, Maryland, Kansas, Iowa and Wisconsin are coordinating their efforts to seek compensation from the company, an official said.
और पढो »

Five U.S. states sue Purdue Pharma over marketing, selling of opioidsFive U.S. states sue Purdue Pharma over marketing, selling of opioidsFive U.S. states on Thursday filed lawsuits accusing Purdue Pharma LP of illegal...
और पढो »

Pennsylvania sues Oxycontin maker Purdue PharmaPennsylvania sues Oxycontin maker Purdue PharmaNEW: Pennsylvania has filed a lawsuit against Purdue Pharma, claiming the Oxycontin maker fueled the state's deadly opioid epidemic through a deceptive marketing campaign that targeted the elderly and military veterans.
और पढो »

Pennsylvania attorney general sues Purdue Pharma over opioid epidemicPennsylvania attorney general sues Purdue Pharma over opioid epidemicPennsylvania Attorney General Josh Shapiro says Purdue Pharma is responsible for an opioid epidemic that has ravaged the state. On Tuesday, he announced that he had sued the pharmaceutical giant over it.
और पढो »

Citing opioid ties, the Met says it will no longer accept gifts from the Sackler familyCiting opioid ties, the Met says it will no longer accept gifts from the Sackler familyThe decision comes after public outcry over the donor’s connection to Purdue Pharma.
और पढो »

Purdue Pharma’s Sacklers to Get Back More Than $90 Million From Boston FundPurdue Pharma’s Sacklers to Get Back More Than $90 Million From Boston FundA small Boston mutual fund is giving back more than $90 million to the Sackler family, owners of OxyContin maker Purdue Pharma.
और पढो »

The Met Stops Taking Gifts From Purdue Pharma’s SacklersThe Met Stops Taking Gifts From Purdue Pharma’s SacklersThe Metropolitan Museum of Art in New York will stop accepting donations from members of the Sackler family associated with drugmaker Purdue Pharma, the latest institution to halt gifts amid scrutiny of the drug company’s role in the opioid epidemic.
और पढो »

The Met is no longer taking money from the Sackler family, makers of OxyContinThe Met is no longer taking money from the Sackler family, makers of OxyContinNew York's Metropolitan Museum of Art says it no longer will take donations from the Sackler family, who's company Purdue Pharma makes Oxycontin. The Met said in a statement Wednesday that it decided to end the relationship with the Sackler's because of their companies 'production of opioids and the ensuing health crisis surrounding the abuse of these medications.'
और पढो »

Dispensed: Troubles at uBiome, pharma giant Merck's plan to upend the $20 billion HIV market, and why insurers are starting to embrace brands like SmileDirectClubDispensed: Troubles at uBiome, pharma giant Merck's plan to upend the $20 billion HIV market, and why insurers are starting to embrace brands like SmileDirectClubWelcome to Dispensed, our weekly dispatch of healthcare, biotech, and pharma news from Business Insider.
और पढो »



Render Time: 2025-02-26 17:32:52